| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland; 2Department of Urology, Tulane Health Sciences Center, New Orleans, Louisiana; and 3Division of Cardiology, Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland
Submitted 5 February 2005 ; accepted in final form 20 October 2006
Since both increased nitric oxide (NO) synthase (NOS) abundance and diminished NO signaling have been reported in the aging penis, the role of NO in the adaptations of aging remains controversial. Here we tested the hypothesis that arginase, an enzyme that competes with NOS for the substrate L-arginine, contributes to erectile dysfunction with advanced age in the B6/129 mouse strain. Arginase protein abundance, mRNA expression, and enzyme activity were elevated in aged compared with young penile endothelial cells. In addition, endothelial NOS (NOS3) protein abundance was greater in aged versus young penile endothelial cells, whereas NOS activity and cGMP levels were reduced. Calcium-dependent L-arginine-to-L-citrulline conversion and cGMP formation increased significantly in aged mouse penes in the presence of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH). However, there was no effect on L-arginine-to-L-citrulline conversion or cGMP accumulation in the endothelium from young mouse penes. To assess the functional role of arginase in the inhibition of NOS pathway responsiveness in the penis, we evaluated the effects of ABH and an adeno-associated virus encoding an antisense sequence to arginase I (AAVanti-arginase) on erectile function in vivo. ABH and AAVanti-arginase enhanced endothelium-dependent erectile responses in the aged mice without altering endothelium-independent responses. Paralleling our in vitro observations, ABH or AAVanti-arginase did not affect vascular responses in the young mice. Inhibition of the arginase pathway improves endothelial function in the aging penile circulation, suggesting that the arginase pathway may be exploited to improve erectile dysfunction associated with aging.
nitric oxide; endothelial nitric oxide synthase; cardiovascular aging
This article has been cited by other articles:
|
|
 |
|
  J. H. Kim, L. J. Bugaj, Y. J. Oh, T. J. Bivalacqua, S. Ryoo, K. G. Soucy, L. Santhanam, A. Webb, A. Camara, G. Sikka, et al. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats J Appl Physiol, October 1, 2009; 107(4): 1249 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. D. Kanika, M. Tar, Y. Tong, D. S. R. Kuppam, A. Melman, and K. P. Davies The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway Am J Physiol Cell Physiol, October 1, 2009; 297(4): C916 - C927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Campen Nitric Oxide Synthase: "Enzyme Zero" in Air Pollution-Induced Vascular Toxicity Toxicol. Sci., July 1, 2009; 110(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Weiss, H. C. Champion, J. A. Williams, W. A. Baumgartner, and A. S. Shah Long-acting oral phosphodiesterase inhibition preconditions against reperfusion injury in an experimental lung transplantation model. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1249 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Santhanam, D. W. Christianson, D. Nyhan, and D. E. Berkowitz Arginase and vascular aging J Appl Physiol, November 1, 2008; 105(5): 1632 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ryoo, G. Gupta, A. Benjo, H. K. Lim, A. Camara, G. Sikka, H. K. Lim, J. Sohi, L. Santhanam, K. Soucy, et al. Endothelial Arginase II: A Novel Target for the Treatment of Atherosclerosis Circ. Res., April 25, 2008; 102(8): 923 - 932. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
